- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Cipla adds capacity of captive renewable energy power plant in Maharashtra, Karnataka
The project will support the Company's green energy requirements for its manufacturing units at Kurkumbh & Patalganga and R&D centre at Vikhroli in Maharashtra, replacing around 70 % of total consumption for these unit to green energy.
New Delhi: Cipla Limited has recently announced the commercial operation of additional capacity of captive renewable energy power plant in Maharashtra & Karnataka.
In Jan'21, Cipla had commissioned 30 MWp solar project at Tuljapur, and now further added 16 MWp of solar capacity for supplying the renewable energy for its manufacturing units/ facilities in Maharashtra. These projects have been commissioned in partnership with AMP Energy India.
The project will support the Company's green energy requirements for its manufacturing units at Kurkumbh & Patalganga and R&D centre at Vikhroli in Maharashtra, replacing around 70 % of total consumption for these unit to green energy. In Karnataka wind solar hybrid captive power plant with capacity as 9 MWp solar + 2.7 MVA of wind has been commissioned in partnership with CleanMax Enviro Energy Solutions, this project will help in migrating the 85 % of power requirement to renewable source for its manufacturing units in Karnataka.
Ms. Geena Malhotra, President and Global Head – Manufacturing Operations, Cipla, commented, "Sustainability is at the core of Cipla's DNA and this project is a big step forward in our goal to achieve carbon neutrality by 2025. We endeavour to continue growing the share of renewable energy across our sites with an aim to contribute to India's agenda of increasing energy generation from non-fossil fuel sources."
Over last 3-year Cipla has added significant capacity of 66 MWp of equivalent solar power portfolio through various initiatives such as an on-site solar roof top & ground mounted solar projects under RESCO model, and captive solar / wind open access project in partnership with leading IPP (Independent Power Producers).
In FY 22, the company has sourced total 68200 mWh of renewal power for its operation across India, leading to 56000 tons of Co2 reductions.
"The company's Global ESG positioning C.A.R.E: Championing Climate Positivity| Accelerating Community Well-being | Raising the Bar on Governance | Enhancing Access & Affordability is aimed at developing a holistic sustainability road map for the future. By 2025, Cipla plans to achieve carbon and water neutrality, zero-waste to landfill, anti-microbial resistance stewardship and green chemistry," the company stated in its recent release.
Read also: Cipla Health's Maxirich signs actor Ayushmann Khurrana as its brand ambassador
Ruchika Sharma joined Medical Dialogue as an Correspondent for the Business Section in 2019. She covers all the updates in the Pharmaceutical field, Policy, Insurance, Business Healthcare, Medical News, Health News, Pharma News, Healthcare and Investment. She has completed her B.Com from Delhi University and then pursued postgraduation in M.Com. She can be contacted at editorial@medicaldialogues.in Contact no. 011-43720751